Pectointercostal Fascial Plane Block Versus Transversus Thoracic Plane Block In Adult Cardiac Surgery Patients
Ultrasound Guided Pectointercostal Fascial Plane Block Versus Transversus Thoracic Plane Block In Adult Cardiac Surgery Patients: A Comparative Study
1 other identifier
interventional
60
1 country
1
Brief Summary
The study will be designed to compare the analgesic effect of ultrasound-guided pectointercostal fascial plane block versus tansversus thoracic plane block in adult cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2022
CompletedStudy Start
First participant enrolled
March 30, 2022
CompletedFirst Posted
Study publicly available on registry
April 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedApril 12, 2022
March 1, 2022
6 months
March 21, 2022
April 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the analgesic effectiveness of the two blocks on midline sternotomy pain,
Postoperative pain evaluation after extubation will be done using the Visual Analogue Scale (VAS). a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between 0 "no pain" and 10 "worst pain."
from end of surgery till discharge from ICU (96 hours)
Secondary Outcomes (2)
pulmonary complications
from end of surgery till discharge from ICU (96 hours)
length of stay in ICU
average 4 days
Study Arms (2)
Pectointercostal Group (n=30)
ACTIVE COMPARATORThey will receive ultrasound-guided pectointercostal fascial block after induction of anesthesia with equal dose before extubation in the intensive care.
Transversus thoracic Group (n=30)
ACTIVE COMPARATORThey will receive ultrasound-guided ultrasound-guided transversus thoracic plane block after induction of anesthesia with equal dose before extubation in the intensive care.
Interventions
Bupivacaine injection by the use of ultrasound in the pectointercostal fascial plane in one group and in the trasversus thoracic plane in the other group.
Eligibility Criteria
You may qualify if:
- Adult patient.
- Elective cardiac surgery.
You may not qualify if:
- Refusal to participate.
- Redo or urgent cardiac surgery.
- Local infection of the skin at the site of needle puncture.
- Allergy to bupivacaine.
- Coagulation disorders.
- Clinically significant liver or kidney disease, heart failure, moderate to severe pulmonary hypertension.
- when extubation is intentionally planned to be delayed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandria University Hospitals
Alexandria, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
islam Omar, MD
Lecturer of Anaesthesia and surgical intensive care, Faculty of medicine, Alexandria university
- PRINCIPAL INVESTIGATOR
Ibrahim Ibrahim, MD
Lecturer of Anaesthesia and surgical intensive care, Faculty of medicine, Alexandria university
- STUDY DIRECTOR
Moustafa Halwag, MD
Lecturer of Anaesthesia and surgical intensive care, Faculty of medicine, Alexandria university
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2022
First Posted
April 12, 2022
Study Start
March 30, 2022
Primary Completion
October 1, 2022
Study Completion
December 1, 2022
Last Updated
April 12, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Immediately after publication No end date
- Access Criteria
- Any one who wishes to access the data
All of the individual participant data collected during the trial, after deidentification